Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Once-Daily vs Twice-Daily Asenapine for Schizophrenia
NCT01549041Phase 4Completed
- Sponsor
- Duke University
- Start
- Apr 2012
- Primary completion
- Apr 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of asenapine in schizophrenia, schizoaffective disorder, sponsored by Duke University. Started Apr 2012; status: completed.
02
Drugs
asenapine
03
Conditions
schizophreniaschizoaffective disorder
Beyond the preview
Go deeper on NCT01549041.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01549041.